A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease

NCT01458470 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Huntington Disease

Interventions

DRUG: Memantine
OTHER: Placebo

Sponsor

University of British Columbia

Collaborators

[object Object]
[object Object]